GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pfenex Inc (AMEX:PFNX) » Definitions » Beginning Cash Position

Pfenex (Pfenex) Beginning Cash Position : $65.80 Mil (As of Jun. 2020)


View and export this data going back to 2014. Start your Free Trial

What is Pfenex Beginning Cash Position?

Pfenex's Beginning Cash Position for the quarter that ended in Jun. 2020 was $65.80 Mil.

Pfenex's quarterly Beginning Cash Position increased from Dec. 2019 ($32.72 Mil) to Mar. 2020 ($55.82 Mil) and increased from Mar. 2020 ($55.82 Mil) to Jun. 2020 ($65.80 Mil).

Pfenex's annual Beginning Cash Position declined from Dec. 2017 ($81.50 Mil) to Dec. 2018 ($57.86 Mil) and declined from Dec. 2018 ($57.86 Mil) to Dec. 2019 ($56.42 Mil).


Pfenex Beginning Cash Position Historical Data

The historical data trend for Pfenex's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfenex Beginning Cash Position Chart

Pfenex Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Beginning Cash Position
Get a 7-Day Free Trial 45.72 110.12 81.50 57.86 56.42

Pfenex Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.95 41.82 32.72 55.82 65.80

Pfenex Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Pfenex Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Pfenex's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfenex (Pfenex) Business Description

Traded in Other Exchanges
N/A
Address
10790 Roselle Street, San Diego, CA, USA, 92121
Pfenex Inc is a clinical-stage biotechnology company involved in the development of protein production and bioanalytic technology. The biosimilars portfolio include PF582, for the treatment of patients with retinal diseases; PF530, designed to treat patients with multiple sclerosis; and PF708, to treat osteoporosis patients at high risk of fractures. Its vaccine portfolio consists of Px563L, a novel anthrax vaccine candidate to meet U.S. government demand, funded by the U.S. Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority.
Executives
Ligand Pharmaceuticals Inc 10 percent owner 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO CA 92121
Phillip M Schneider director GEN-PROBE INCORPORATED, 10210 GENETIC CENTER DRIVE, SAN DIEGO CA 92121
Jason Grenfell-gardner director 105 LINCOLN AVENUE BUENA NJ 08310
Patrick K. Lucy officer: Chief Business Officer C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Robin Campbell director C/O PFENEX INC., 10790 ROSELLE STREET SAN DIEGO CA 92121
Magda Marquet director ALTHEADX INC., 3550 DUNHILL STREET, SAN DIEGO CA 92121
John Mack Taylor director C/O PFENEX, INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Evert B. Schimmelpennink director, officer: See Remarks C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Shawn Scranton officer: Chief Operating Officer C/O PFENEX INC 10790 ROSELLE STREET SAN DIEGO CA 92121
Martin Brenner officer: Chief Scientific Officer C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Lorianne Masuoka director C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Newtyn Management, Llc 10 percent owner 60 EAST 42ND STREET, 9TH FLOOR, NEW YORK NY 10165
Weiss Asset Management Lp 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Andrew M Weiss 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Wam Gp Llc 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116

Pfenex (Pfenex) Headlines

From GuruFocus

Pfenex Appoints Dr. Martin B. Brenner as Chief Scientific Officer

By Marketwired Marketwired 03-18-2019